Anti-PF4V/ PF4V1/ CXCL4L1 functional antibody

Anti-PF4V/ PF4V1/ CXCL4L1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to PF4V1/PF4V1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1179-Ab-1/ GM-Tg-hg-SE1179-Ab-2Anti-Human PF4V1 monoclonal antibodyHuman
GM-Tg-rg-SE1179-Ab-1/ GM-Tg-rg-SE1179-Ab-2Anti-Rat PF4V1 monoclonal antibodyRat
GM-Tg-mg-SE1179-Ab-1/ GM-Tg-mg-SE1179-Ab-2Anti-Mouse PF4V1 monoclonal antibodyMouse
GM-Tg-cynog-SE1179-Ab-1/ GM-Tg-cynog-SE1179-Ab-2Anti-Cynomolgus/ Rhesus macaque PF4V1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1179-Ab-1/ GM-Tg-felg-SE1179-Ab-2Anti-Feline PF4V1 monoclonal antibodyFeline
GM-Tg-cang-SE1179-Ab-1/ GM-Tg-cang-SE1179-Ab-2Anti-Canine PF4V1 monoclonal antibodyCanine
GM-Tg-bovg-SE1179-Ab-1/ GM-Tg-bovg-SE1179-Ab-2Anti-Bovine PF4V1 monoclonal antibodyBovine
GM-Tg-equg-SE1179-Ab-1/ GM-Tg-equg-SE1179-Ab-2Anti-Equine PF4V1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1179-Ab-1/ GM-Tg-hg-SE1179-Ab-2; GM-Tg-rg-SE1179-Ab-1/ GM-Tg-rg-SE1179-Ab-2;
GM-Tg-mg-SE1179-Ab-1/ GM-Tg-mg-SE1179-Ab-2; GM-Tg-cynog-SE1179-Ab-1/ GM-Tg-cynog-SE1179-Ab-2;
GM-Tg-felg-SE1179-Ab-1/ GM-Tg-felg-SE1179-Ab-2; GM-Tg-cang-SE1179-Ab-1/ GM-Tg-cang-SE1179-Ab-2;
GM-Tg-bovg-SE1179-Ab-1/ GM-Tg-bovg-SE1179-Ab-2; GM-Tg-equg-SE1179-Ab-1/ GM-Tg-equg-SE1179-Ab-2
Products NameAnti-PF4V1 monoclonal antibody
Formatmab
Target NamePF4V1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PF4V1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1179-Ag-1Recombinant multi-species PF4V/ PF4V1/ CXCL4L1 protein
    ORF Viral VectorvGMLV000280human PF4V1 Lentivirus particle
    ORF Viral VectorvGMLP003152human PF4V1 Lentivirus particle
    ORF Viral VectorpGMLV000280human PF4V1 Lentivirus plasmid
    ORF Viral VectorpGMLP003152human PF4V1 Lentivirus plasmid


    Target information

    Target IDGM-SE1179
    Target NamePF4V1
    Gene ID5197,703895
    Gene Symbol and SynonymsCXCL4L1,CXCL4V1,PF4-ALT,PF4A,PF4V1,SCYB4V1
    Uniprot AccessionP10720
    Uniprot Entry NamePF4V_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000109272
    Target ClassificationN/A

    The target: PF4V1, gene name: PF4V1, also named as CXCL4L1, CXCL4V1, PF4-ALT, PF4A, SCYB4V1. The protein encoded by this gene is a chemokine that is highly similar to platelet factor 4. The encoded protein displays a strong antiangiogenic function and is regulated by chemokine (C-X-C motif) receptor 3. This protein also impairs tumor growth and can protect against blood-retinal barrier breakdown in diabetes patients. [provided by RefSeq, Nov 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.